News
340 B Drug Pricing Program Controversy: Hospitals, Pharma Giants and $81 Billion in Drug Discounts
5+ hour, 53+ min ago (866+ words) The 340 B Drug Pricing Program has become a major battleground between hospitals and pharmaceutical manufacturers. As healthcare costs continue to rise across the United States, the debate surrounding the 340 B program has intensified. Supporters argue that it provides essential financial…...
Symbols: nyse:abbv,btc-usd